Dexcom G5 Mobile
There appears to be no peer-reviewed clinical validation information available on the technology used in the Dexcom G5 Mobile to measure blood glucose.
|Medaval||Not recommended||This device has not been clinically validated.|
Vandersluis S, Kabali C, Djalalov S, Gajic-Veljanoski O, Wells D and Holubowich C on behalf of Health Quality Ontario. Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment. Ont Health Technol Assess Ser. 2018 Feb 21;18(2):1-160. PMID: 29541282. Available from: PMC5836597. eCollection 2018.
The publication describes the use of the Dexcom G5 Mobile in a scientific study.
Freckmann G, Link M, Pleus S, Westhoff A, Kamecke U, Haug C. Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose Monitoring. J Diabetes Sci Technol. 2018 Aug;20(8):541-549. doi: 10.1089/dia.2018.0105. PMID: 30067410. Available from: PMC6080122.
The publication evaluates the performance of the Dexcom G5 Mobile, though not in a formal validation.
Approximately 25% of results showed differences from reference results exceeding 15 mg/dL, at glucose concentration below 100 mg/dL, or exceeding 15%, at glucose concentration above 100 mg/dL, at times of therapeutic decisions.